KR20200043972A - 보철용 임플란트 및 손상된 신경 조직의 외과적 치료 방법, 다공성 폴리테트라플루오로에틸렌 사용 - Google Patents
보철용 임플란트 및 손상된 신경 조직의 외과적 치료 방법, 다공성 폴리테트라플루오로에틸렌 사용 Download PDFInfo
- Publication number
- KR20200043972A KR20200043972A KR1020207000730A KR20207000730A KR20200043972A KR 20200043972 A KR20200043972 A KR 20200043972A KR 1020207000730 A KR1020207000730 A KR 1020207000730A KR 20207000730 A KR20207000730 A KR 20207000730A KR 20200043972 A KR20200043972 A KR 20200043972A
- Authority
- KR
- South Korea
- Prior art keywords
- nerve tissue
- implant
- nerve
- spinal cord
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000007943 implant Substances 0.000 title claims abstract description 65
- 210000000944 nerve tissue Anatomy 0.000 title claims abstract description 49
- 229920001343 polytetrafluoroethylene Polymers 0.000 title claims abstract description 40
- 239000004810 polytetrafluoroethylene Substances 0.000 title claims abstract description 40
- -1 polytetrafluoroethylene Polymers 0.000 title claims abstract description 8
- 238000001356 surgical procedure Methods 0.000 title claims description 7
- 210000000278 spinal cord Anatomy 0.000 claims abstract description 74
- 239000011148 porous material Substances 0.000 claims abstract description 38
- 238000000034 method Methods 0.000 claims abstract description 31
- 230000006378 damage Effects 0.000 claims description 27
- 210000001519 tissue Anatomy 0.000 claims description 17
- 230000001338 necrotic effect Effects 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 9
- 210000000860 cochlear nerve Anatomy 0.000 claims description 5
- 210000001328 optic nerve Anatomy 0.000 claims description 4
- 230000017074 necrotic cell death Effects 0.000 claims description 3
- 230000000451 tissue damage Effects 0.000 claims description 2
- 231100000827 tissue damage Toxicity 0.000 claims description 2
- 208000014674 injury Diseases 0.000 abstract description 13
- 230000008569 process Effects 0.000 abstract description 8
- 230000001154 acute effect Effects 0.000 abstract description 5
- 230000018044 dehydration Effects 0.000 abstract description 5
- 238000006297 dehydration reaction Methods 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 230000004064 dysfunction Effects 0.000 abstract description 4
- 230000008733 trauma Effects 0.000 abstract description 3
- 210000005036 nerve Anatomy 0.000 description 28
- 241000700159 Rattus Species 0.000 description 23
- 230000000694 effects Effects 0.000 description 23
- 210000000115 thoracic cavity Anatomy 0.000 description 17
- 231100000241 scar Toxicity 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 210000002569 neuron Anatomy 0.000 description 12
- 241000282472 Canis lupus familiaris Species 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 102100033639 Acetylcholinesterase Human genes 0.000 description 9
- 108010022752 Acetylcholinesterase Proteins 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 208000032544 Cicatrix Diseases 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 230000037387 scars Effects 0.000 description 8
- 210000002808 connective tissue Anatomy 0.000 description 7
- 208000020431 spinal cord injury Diseases 0.000 description 7
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 6
- 210000003050 axon Anatomy 0.000 description 6
- 230000001744 histochemical effect Effects 0.000 description 6
- 210000004126 nerve fiber Anatomy 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- 230000001172 regenerating effect Effects 0.000 description 6
- 210000003169 central nervous system Anatomy 0.000 description 5
- 230000001713 cholinergic effect Effects 0.000 description 5
- 230000001537 neural effect Effects 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 4
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 4
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 4
- 229940022698 acetylcholinesterase Drugs 0.000 description 4
- 230000001086 cytosolic effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 4
- 210000004116 schwann cell Anatomy 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 208000037816 tissue injury Diseases 0.000 description 4
- 239000004604 Blowing Agent Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 210000004498 neuroglial cell Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 210000001130 astrocyte Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000001734 parasympathetic effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000001032 spinal nerve Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 230000028600 axonogenesis Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002518 glial effect Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000001937 intercostal nerve Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
- A61B17/1128—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis of nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L27/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers
- C08L27/02—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L27/12—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers not modified by chemical after-treatment containing fluorine atoms
- C08L27/18—Homopolymers or copolymers or tetrafluoroethene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
- A61F2002/0081—Special surfaces of prostheses, e.g. for improving ingrowth directly machined on the prosthetic surface, e.g. holes, grooves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BYA20170215 | 2017-06-13 | ||
| BY20170215 | 2017-06-13 | ||
| PCT/BY2017/000017 WO2018227264A1 (en) | 2017-06-13 | 2017-09-26 | Implant for injured nerve tissue prosthetics, method of surgical treatment for injured nerve tissue and use of porous polytetrafluorethylene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20200043972A true KR20200043972A (ko) | 2020-04-28 |
Family
ID=60153014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020207000730A Ceased KR20200043972A (ko) | 2017-06-13 | 2017-09-26 | 보철용 임플란트 및 손상된 신경 조직의 외과적 치료 방법, 다공성 폴리테트라플루오로에틸렌 사용 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200138439A1 (enExample) |
| EP (1) | EP3638325A1 (enExample) |
| JP (1) | JP7055269B2 (enExample) |
| KR (1) | KR20200043972A (enExample) |
| CN (1) | CN111093722A (enExample) |
| CA (1) | CA3067050A1 (enExample) |
| EA (1) | EA201900579A1 (enExample) |
| IL (1) | IL271632A (enExample) |
| WO (1) | WO2018227264A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12115058B2 (en) * | 2019-02-22 | 2024-10-15 | Toray Industries, Inc. | Nerve regeneration-inducing tube |
| CN114917406B (zh) * | 2022-04-14 | 2023-08-08 | 北京大学第三医院（北京大学第三临床医学院） | 一种能够促进自我选择性神经修复的纳米管 |
| WO2025091101A1 (en) | 2023-11-02 | 2025-05-08 | Joint Stock Company 'altimed' | Suture material and surgical suture kit |
| WO2025189269A1 (en) * | 2024-03-15 | 2025-09-18 | Joint Stock Company 'altimed' | Implant for injured nerve tissue regeneration and use of implant |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU564103B2 (en) * | 1983-02-02 | 1987-07-30 | Minnesota Mining And Manufacturing Company | Absorbable nerve repair device and method |
| US4877029A (en) * | 1987-03-30 | 1989-10-31 | Brown University Research Foundation | Semipermeable nerve guidance channels |
| US6102921A (en) * | 1990-12-21 | 2000-08-15 | University Of New Mexico | Nerve anastomosis sling and method |
| RU2195941C2 (ru) | 2000-06-19 | 2003-01-10 | Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН | Способ лечения травматических повреждений спинного мозга |
| US20030181978A1 (en) | 2002-03-25 | 2003-09-25 | Brown Kelly R. | Channeled biomedical foams and method for producing same |
| US8202725B2 (en) * | 2004-12-23 | 2012-06-19 | Tissue Genesis Incorporated | Cell sodding method and apparatus |
| BY10325C1 (en) | 2002-04-23 | 2003-12-30 | Closed Joint Stock Company | Method for producing a porous implant from titanium powder |
| US7147647B2 (en) | 2002-04-26 | 2006-12-12 | Medtronic, Inc. | Sintered titanium tube for the management of spinal cord injury |
| US7931687B2 (en) * | 2002-05-13 | 2011-04-26 | Articular Engineering, Llc | Tissue engineered osteochondral implant |
| US20060287659A1 (en) * | 2003-08-22 | 2006-12-21 | Tepha, Inc. | Polyhydroxyalkanoate nerve regeneration devices |
| US7846466B2 (en) * | 2004-06-10 | 2010-12-07 | Northwestern University | Biodegradable scaffolds and uses thereof |
| KR101649457B1 (ko) * | 2006-04-25 | 2016-08-19 | 칠드런'즈 메디컬 센터 코포레이션 | 개방창 및 폐쇄창 척수 손상의 치료를 위한 방법 및 조성물 |
| CN101653366B (zh) | 2009-06-11 | 2011-06-08 | 广州中大中山医科技开发有限公司 | 一种用于修复神经损伤的明胶海绵圆柱体支架的构建 |
| JP2013518591A (ja) * | 2010-02-02 | 2013-05-23 | ザ キュレーターズ オブ ザ ユニバーシティ オブ ミズーリ | 改変された生物学的神経移植片の製造およびその用途 |
| RU2608237C2 (ru) * | 2010-11-03 | 2017-01-17 | ЭТИКОН ЭлЭлСи | Самоудерживающиеся шовные материалы, выделяющие лекарственные средства, и относящиеся к ним методы |
| EP2750725B1 (en) | 2011-09-01 | 2020-09-16 | Anatoli D. Dosta | Dental implant, vascular implant and tissue implant made of porous three-dimensional structure of polytetrafluoroethylene |
| CN106421912A (zh) * | 2016-10-13 | 2017-02-22 | 中山大学 | 一种基质化去细胞神经支架的制备和应用 |
-
2017
- 2017-09-26 EP EP17787310.6A patent/EP3638325A1/en not_active Withdrawn
- 2017-09-26 JP JP2019569726A patent/JP7055269B2/ja active Active
- 2017-09-26 EA EA201900579A patent/EA201900579A1/ru unknown
- 2017-09-26 CN CN201780093021.4A patent/CN111093722A/zh active Pending
- 2017-09-26 WO PCT/BY2017/000017 patent/WO2018227264A1/en not_active Ceased
- 2017-09-26 CA CA3067050A patent/CA3067050A1/en not_active Abandoned
- 2017-09-26 KR KR1020207000730A patent/KR20200043972A/ko not_active Ceased
-
2019
- 2019-12-12 US US16/712,379 patent/US20200138439A1/en not_active Abandoned
- 2019-12-22 IL IL271632A patent/IL271632A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020523165A (ja) | 2020-08-06 |
| IL271632A (en) | 2020-02-27 |
| CN111093722A (zh) | 2020-05-01 |
| WO2018227264A1 (en) | 2018-12-20 |
| JP7055269B2 (ja) | 2022-04-18 |
| EP3638325A1 (en) | 2020-04-22 |
| EA201900579A1 (ru) | 2020-04-21 |
| CA3067050A1 (en) | 2018-12-20 |
| US20200138439A1 (en) | 2020-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7642523B2 (ja) | 組織移植および複製のための方法および装置 | |
| JP6817953B2 (ja) | 生体物質の分解装置および対応する製造方法、並びに、細胞懸濁液および組織微小移植片の調製方法 | |
| KR20200043972A (ko) | 보철용 임플란트 및 손상된 신경 조직의 외과적 치료 방법, 다공성 폴리테트라플루오로에틸렌 사용 | |
| Deng et al. | Evaluation of efficacy and biocompatibility of a new absorbable synthetic substitute as a dural onlay graft in a large animal model | |
| Wu et al. | Development of cryogel-based guidance conduit for peripheral nerve regeneration | |
| Schenck et al. | A full skin defect model to evaluate vascularization of biomaterials in vivo | |
| Bayram et al. | Effects of platelet-rich fibrin membrane on sciatic nerve regeneration | |
| Hostettler et al. | Clinical studies and pre-clinical animal models on facial Nerve preservation, Reconstruction, and regeneration following Cerebellopontine Angle Tumor Surgery–A Systematic Review and Future Perspectives | |
| US20170354757A1 (en) | Implant for Lymph Node Formation/Regeneration | |
| Li et al. | BDNF-loaded chitosan-based mimetic mussel polymer conduits for repair of peripheral nerve injury | |
| RU2438623C1 (ru) | Способ формирования биосовместимой структуры | |
| Baskov et al. | Laser Reconstruction of Spinal Discs Experiments and Clinic | |
| Nie et al. | Dumbbell-shaped hydrogel plug for annulus fibrosus repair: From material design to in vivo validation | |
| Kumar et al. | Natural Biomaterials for Tissue Engineering | |
| Peplow et al. | Tissue reaction to matrices of reconstituted keratin polymer implanted subcutaneously in sheep | |
| Chuang et al. | Injured nerves respond favorably to an integrated tension-and conduit-based regenerative strategy | |
| Cerci et al. | In vivo evaluation of biomaterials for neural tissue engineering | |
| Eastep | A Comparative Biomechanical Investigation of Porcine Neonatal and Adult Left Ventricular Tissues | |
| Vieira et al. | Comparison of Bone Graft Preparations to Treat a Critical Bone Defect on a Rodent Animal Model | |
| Sloan | Tissue-Engineered Annulus Fibrosus Repair and Nucleus Pulposus Augmentation in Pre-Clinical Models of Intervertebral Disc Degeneration | |
| RU2387418C2 (ru) | Способ фиксации глазного яблока после удаления верхней челюсти | |
| CN118526638A (zh) | 一种水凝胶及其制备方法和应用 | |
| IL293612A (en) | Devices and methods of deployment of extracellular matrix systems | |
| Kuznetsov et al. | The fabrication of bioresorbable implants for bone defects replacement using computer tomogram and 3D printing | |
| Ghosh et al. | The utility of 3D ultramicroscopy for evaluating cellular therapies after spinal cord injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20200109 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210716 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20220427 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20210716 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |